rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

fy2003

Rediff.com  »  News  »   fy2003

  News for fy2003

  • News
  • Business

The Nehruvian Penalty: 50 wasted years

The Goldman Sachs report 'Dreaming with BRICs: The Path 2050' by Dominic Wilson and Roopa Purushothaman, dated October 31, 2003, has, with good reason, caused quite a stir, especially in India. It......

Want to head the Indo-US S&T Forum?

Executive Director for Indo-US Science and Technology ForumThe Indo-US Science and Technology Forum (http://www.indousstf.org) is seeking applications from suitable candidates for the appointment......

Digital GlobalSoft issues outlook

Digital GlobalSoft Ltd has issued the following business outlook for FY2003:All -round progress at the operating level and having a wide range of service offerings is in line with the Company's......

Why Morgan Stanley is upbeat about the Indian economy

Predicting an average sub-5 per cent inflation this year, Morgan Stanley has said India is in for a long period of higher sustainable growth and lower prices. "We are more constructive on inflation......

Budget: Will it usher in speedy recovery?

How the Government uses Union Budget to usher in speedy recovery for India and at the same time balance the fisc, which is slowly going out of proportions, remains to be seenUnion Budget 2009-10......

What is a cash flow statement?

Complementing the balance sheet and income statement, the cash flow statement, a mandatory part of a company's financial reports since 1987, records the amounts of cash and cash equivalents......

10 good construction stocks to invest in

Mega investments in infrastructure and the recent market correction offers an exciting investment opportunity in construction stocks.The robust GDP growth rate experienced by the country in the......
  Web results for fy2003
Zydus receives US FDA approval to market pyridostigmine bromide tablets

Zydus Cadila, an Ahmedabad-based innovative, global pharmaceutical company, has received the final approval from the US Food and Drug... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=89075&sid=2
Cadilla Healthcare gains on USFDA nod for neurological drug

Email this Print Shares of Cadilla Healthcare were up over 2% at Rs 1,768 after the company said that it has received final approval to market... ...

http://smartinvestor.business-standard.com/market/Marketnews-319692-Marketnewsdet-Cadilla_Healthcare_gains_on_USFDA_nod_for_neurological_drug.htm
Largecap/midcap PE ratio is trading at 30% discount; ICICI, L&T, Maruti among top 5 stocks to bet on

The Largecap/midcap PE ratio is at a 30% discount to its long-term average, indicating that largecaps provide an attractive entry point, says... ...

http://economictimes.indiatimes.com/opinion/interviews/largecap/midcap-pe-ratio-is-trading-at-30-discount-icici-lt-maruti-among-top-5-stocks-to-bet-on/articleshow/47768370.cms
Maha IT policy offers exemption in taxes, additional FSI for IT and ITeS indutry

The IT policy eyes on Rs 50,000 crore investments, employment to over 1 million people by 2020 Rolling out various attractive incentive schemes... ...

http://www.dqweek.com/maha-it-policy-offers-exemption-in-taxes-additional-fsi-for-it-ites-units/

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z